

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 6.42954211 |
| 2 | central nervous system myelination (GO:0022010) | 6.42954211 |
| 3 | myelination (GO:0042552) | 5.48735177 |
| 4 | ensheathment of neurons (GO:0007272) | 5.46229889 |
| 5 | axon ensheathment (GO:0008366) | 5.46229889 |
| 6 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.99667936 |
| 7 | fatty acid elongation (GO:0030497) | 4.79009898 |
| 8 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.70119920 |
| 9 | detection of molecule of bacterial origin (GO:0032490) | 4.49603052 |
| 10 | presynaptic membrane assembly (GO:0097105) | 4.32139778 |
| 11 | negative regulation of neurotransmitter transport (GO:0051589) | 4.23331638 |
| 12 | negative regulation of interleukin-12 production (GO:0032695) | 4.14349523 |
| 13 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 4.04137954 |
| 14 | cholesterol biosynthetic process (GO:0006695) | 4.02383215 |
| 15 | virion attachment to host cell (GO:0019062) | 3.95083267 |
| 16 | adhesion of symbiont to host cell (GO:0044650) | 3.95083267 |
| 17 | Rap protein signal transduction (GO:0032486) | 3.94846754 |
| 18 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.90189987 |
| 19 | presynaptic membrane organization (GO:0097090) | 3.86266540 |
| 20 | regulation of collateral sprouting (GO:0048670) | 3.84505977 |
| 21 | myelination in peripheral nervous system (GO:0022011) | 3.83965579 |
| 22 | peripheral nervous system axon ensheathment (GO:0032292) | 3.83965579 |
| 23 | response to peptidoglycan (GO:0032494) | 3.83355291 |
| 24 | transmission of nerve impulse (GO:0019226) | 3.75746681 |
| 25 | glycosphingolipid catabolic process (GO:0046479) | 3.75369317 |
| 26 | membrane assembly (GO:0071709) | 3.75084009 |
| 27 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.73422290 |
| 28 | limb bud formation (GO:0060174) | 3.73386983 |
| 29 | neuron cell-cell adhesion (GO:0007158) | 3.73325666 |
| 30 | eye photoreceptor cell differentiation (GO:0001754) | 3.64759193 |
| 31 | photoreceptor cell differentiation (GO:0046530) | 3.64759193 |
| 32 | glycerophospholipid catabolic process (GO:0046475) | 3.63687443 |
| 33 | * substantia nigra development (GO:0021762) | 3.60478529 |
| 34 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.59613998 |
| 35 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.58000565 |
| 36 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.57540965 |
| 37 | astrocyte development (GO:0014002) | 3.56593322 |
| 38 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.52194712 |
| 39 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.52098211 |
| 40 | oligodendrocyte differentiation (GO:0048709) | 3.50179626 |
| 41 | sterol biosynthetic process (GO:0016126) | 3.48412981 |
| 42 | cellular response to epinephrine stimulus (GO:0071872) | 3.48222196 |
| 43 | positive regulation of actin filament depolymerization (GO:0030836) | 3.46392775 |
| 44 | negative regulation of axon extension (GO:0030517) | 3.40348997 |
| 45 | isoprenoid biosynthetic process (GO:0008299) | 3.37595492 |
| 46 | oligosaccharide catabolic process (GO:0009313) | 3.36893970 |
| 47 | macrophage activation involved in immune response (GO:0002281) | 3.35373824 |
| 48 | phagocytosis, engulfment (GO:0006911) | 3.30635462 |
| 49 | negative regulation of axonogenesis (GO:0050771) | 3.29079935 |
| 50 | positive regulation of action potential (GO:0045760) | 3.28628442 |
| 51 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.26409005 |
| 52 | glycolipid catabolic process (GO:0019377) | 3.21875350 |
| 53 | regulation of mononuclear cell migration (GO:0071675) | 3.21064243 |
| 54 | regulation of cell communication by electrical coupling (GO:0010649) | 3.20185161 |
| 55 | iron ion import (GO:0097286) | 3.19178250 |
| 56 | T-helper 1 type immune response (GO:0042088) | 3.17128583 |
| 57 | asymmetric protein localization (GO:0008105) | 3.15251332 |
| 58 | regulation of monocyte chemotaxis (GO:0090025) | 3.15094978 |
| 59 | negative regulation of protein localization to cell surface (GO:2000009) | 3.13482643 |
| 60 | response to redox state (GO:0051775) | 3.12303468 |
| 61 | ceramide catabolic process (GO:0046514) | 3.11219175 |
| 62 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.10741939 |
| 63 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.09884498 |
| 64 | cell adhesion mediated by integrin (GO:0033627) | 3.08240766 |
| 65 | regulation of memory T cell differentiation (GO:0043380) | 3.07196563 |
| 66 | response to epinephrine (GO:0071871) | 3.06944666 |
| 67 | positive regulation of interleukin-17 production (GO:0032740) | 3.03270480 |
| 68 | collagen fibril organization (GO:0030199) | 3.01381386 |
| 69 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.00094356 |
| 70 | neuronal ion channel clustering (GO:0045161) | 2.99827088 |
| 71 | neutrophil activation involved in immune response (GO:0002283) | 2.98628729 |
| 72 | regulation of fever generation (GO:0031620) | 2.97041993 |
| 73 | protein targeting to lysosome (GO:0006622) | 2.96639149 |
| 74 | establishment of protein localization to vacuole (GO:0072666) | 2.96639149 |
| 75 | protein targeting to vacuole (GO:0006623) | 2.96639149 |
| 76 | detection of external biotic stimulus (GO:0098581) | 2.96523983 |
| 77 | adhesion of symbiont to host (GO:0044406) | 2.96481757 |
| 78 | peripheral nervous system development (GO:0007422) | 2.95298241 |
| 79 | wound healing, spreading of epidermal cells (GO:0035313) | 2.95281822 |
| 80 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.92911438 |
| 81 | cellular response to monoamine stimulus (GO:0071868) | 2.91757139 |
| 82 | cellular response to catecholamine stimulus (GO:0071870) | 2.91757139 |
| 83 | membrane invagination (GO:0010324) | 2.90034388 |
| 84 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.89665058 |
| 85 | cellular response to ethanol (GO:0071361) | 2.88280994 |
| 86 | apical protein localization (GO:0045176) | 2.86883806 |
| 87 | import into cell (GO:0098657) | 2.86404459 |
| 88 | neurotransmitter catabolic process (GO:0042135) | 2.85364541 |
| 89 | cellular extravasation (GO:0045123) | 2.84676904 |
| 90 | regulation of interferon-alpha production (GO:0032647) | 2.83589574 |
| 91 | protein localization to endosome (GO:0036010) | 2.79985585 |
| 92 | negative regulation of anoikis (GO:2000811) | 2.79703831 |
| 93 | cellular response to interferon-alpha (GO:0035457) | 2.79239794 |
| 94 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.77707831 |
| 95 | regulation of macrophage cytokine production (GO:0010935) | 2.77561623 |
| 96 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.77417020 |
| 97 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.77417020 |
| 98 | modulation by symbiont of host immune response (GO:0052553) | 2.77417020 |
| 99 | positive regulation by symbiont of host defense response (GO:0052509) | 2.77417020 |
| 100 | modulation by symbiont of host defense response (GO:0052031) | 2.77417020 |
| 101 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.77417020 |
| 102 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.76434344 |
| 103 | neuron recognition (GO:0008038) | 2.76013791 |
| 104 | response to catecholamine (GO:0071869) | 2.75848476 |
| 105 | response to monoamine (GO:0071867) | 2.75848476 |
| 106 | detection of other organism (GO:0098543) | 2.74730284 |
| 107 | histamine secretion (GO:0001821) | 2.72849137 |
| 108 | response to lipoprotein particle (GO:0055094) | 2.72369717 |
| 109 | dermatan sulfate biosynthetic process (GO:0030208) | 2.72288859 |
| 110 | protein neddylation (GO:0045116) | 2.70623525 |
| 111 | enteric nervous system development (GO:0048484) | 2.70313714 |
| 112 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.70231570 |
| 113 | positive regulation of leukocyte degranulation (GO:0043302) | 2.69065405 |
| 114 | microglial cell activation (GO:0001774) | 2.68654855 |
| 115 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.68044247 |
| 116 | nerve growth factor signaling pathway (GO:0038180) | 2.67434760 |
| 117 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.67260419 |
| 118 | negative regulation of interleukin-17 production (GO:0032700) | 2.66693678 |
| 119 | negative regulation of mast cell activation (GO:0033004) | 2.64631254 |
| 120 | amino sugar catabolic process (GO:0046348) | 2.64506690 |
| 121 | positive regulation of macrophage cytokine production (GO:0060907) | 2.63132283 |
| 122 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.62135258 |
| 123 | keratan sulfate catabolic process (GO:0042340) | 2.61413131 |
| 124 | dendrite morphogenesis (GO:0048813) | 2.60897878 |
| 125 | magnesium ion transport (GO:0015693) | 2.60831746 |
| 126 | regulation of dendrite morphogenesis (GO:0048814) | 2.60779577 |
| 127 | regulation of mast cell activation (GO:0033003) | 2.60111611 |
| 128 | L-amino acid import (GO:0043092) | 2.59915765 |
| 129 | establishment of mitochondrion localization (GO:0051654) | 2.59902167 |
| 130 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.59354761 |
| 131 | detection of biotic stimulus (GO:0009595) | 2.58981103 |
| 132 | response to hepatocyte growth factor (GO:0035728) | 2.58835303 |
| 133 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.58835303 |
| 134 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.57324517 |
| 135 | macrophage activation (GO:0042116) | 2.57097412 |
| 136 | adult walking behavior (GO:0007628) | 2.56231482 |
| 137 | cerebellar granule cell differentiation (GO:0021707) | 2.55455998 |
| 138 | glial cell migration (GO:0008347) | 2.54691595 |
| 139 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.54536350 |
| 140 | osteoclast differentiation (GO:0030316) | 2.54249307 |
| 141 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.54073732 |
| 142 | positive regulation of mast cell degranulation (GO:0043306) | 2.53944487 |
| 143 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.53944487 |
| 144 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.53499013 |
| 145 | positive regulation of interleukin-6 production (GO:0032755) | 2.52864360 |
| 146 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.52766234 |
| 147 | positive regulation of interferon-alpha production (GO:0032727) | 2.52335879 |
| 148 | regulation of heat generation (GO:0031650) | 2.52203187 |
| 149 | positive regulation of type 2 immune response (GO:0002830) | 2.51847548 |
| 150 | dendritic spine morphogenesis (GO:0060997) | 2.51581492 |
| 151 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.51420015 |
| 152 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.50943764 |
| 153 | Notch signaling involved in heart development (GO:0061314) | 2.49799518 |
| 154 | axon extension involved in axon guidance (GO:0048846) | 2.48800948 |
| 155 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.48800948 |
| 156 | chondrocyte development (GO:0002063) | 2.48750038 |
| 157 | * neural nucleus development (GO:0048857) | 2.48264347 |
| 158 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.47468064 |
| 159 | positive regulation of mast cell activation (GO:0033005) | 2.47432856 |
| 160 | actin filament depolymerization (GO:0030042) | 2.45618984 |
| 161 | Golgi to plasma membrane protein transport (GO:0043001) | 2.45290605 |
| 162 | axonal fasciculation (GO:0007413) | 2.45272785 |
| 163 | negative regulation of interleukin-10 production (GO:0032693) | 2.44209917 |
| 164 | membrane tubulation (GO:0097320) | 2.44046029 |
| 165 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.43688833 |
| 166 | positive regulation of protein depolymerization (GO:1901881) | 2.43131436 |
| 167 | I-kappaB phosphorylation (GO:0007252) | 2.42794982 |
| 168 | phagocytosis, recognition (GO:0006910) | 2.42115405 |
| 169 | dopamine biosynthetic process (GO:0042416) | 2.40524093 |
| 170 | myelin maintenance (GO:0043217) | 2.40429467 |
| 171 | protein palmitoylation (GO:0018345) | 2.40127966 |
| 172 | response to thyroid hormone (GO:0097066) | 2.40012531 |
| 173 | nuclear pore complex assembly (GO:0051292) | 2.39230013 |
| 174 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.38732532 |
| 175 | positive regulation of heat generation (GO:0031652) | 2.38709423 |
| 176 | activated T cell proliferation (GO:0050798) | 2.38146710 |
| 177 | positive regulation of chemokine production (GO:0032722) | 2.37738794 |
| 178 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.37443978 |
| 179 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.37297347 |
| 180 | axon development (GO:0061564) | 2.36859335 |
| 181 | positive regulation of pseudopodium assembly (GO:0031274) | 2.36528536 |
| 182 | lateral sprouting from an epithelium (GO:0060601) | 2.36427007 |
| 183 | collagen catabolic process (GO:0030574) | 2.35787359 |
| 184 | dendrite development (GO:0016358) | 2.35338794 |
| 185 | negative regulation of exocytosis (GO:0045920) | 2.34636593 |
| 186 | dermatan sulfate metabolic process (GO:0030205) | 2.34537155 |
| 187 | collagen metabolic process (GO:0032963) | 2.34364568 |
| 188 | negative regulation of osteoclast differentiation (GO:0045671) | 2.32913959 |
| 189 | regulation of activation of Janus kinase activity (GO:0010533) | 2.32872383 |
| 190 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.32197619 |
| 191 | neuronal action potential propagation (GO:0019227) | 2.32035096 |
| 192 | negative regulation of axon guidance (GO:1902668) | 2.31097887 |
| 193 | amyloid precursor protein metabolic process (GO:0042982) | 2.30362852 |
| 194 | creatine metabolic process (GO:0006600) | 2.28031544 |
| 195 | phosphatidylinositol 3-kinase signaling (GO:0014065) | 2.27941177 |
| 196 | semaphorin-plexin signaling pathway (GO:0071526) | 2.27444191 |
| 197 | cell migration in hindbrain (GO:0021535) | 2.27003838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.57306589 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.31658364 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.22671476 |
| 4 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.01155352 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.82956371 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.68146404 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.66863475 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.63388866 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.60776141 |
| 10 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.59838883 |
| 11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.59455408 |
| 12 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.58338624 |
| 13 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.53421546 |
| 14 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.49934404 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.49327812 |
| 16 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.47017823 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.45803731 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.38971896 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32206278 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31297432 |
| 21 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.29784399 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.29064080 |
| 23 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.28801443 |
| 24 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.27248171 |
| 25 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.26467932 |
| 26 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.25382210 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.21214415 |
| 28 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.21076316 |
| 29 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.20589173 |
| 30 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.19683830 |
| 31 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.19683830 |
| 32 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.19331521 |
| 33 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.08786379 |
| 34 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.08463152 |
| 35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.06859671 |
| 36 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.05206440 |
| 37 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.03936627 |
| 38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.02528589 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 2.02345366 |
| 40 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.99468020 |
| 41 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.92835846 |
| 42 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.91832481 |
| 43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.88595930 |
| 44 | CJUN_26792858_Chip-Seq_BT549_Human | 1.86914307 |
| 45 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.85926444 |
| 46 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.83112812 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.81110935 |
| 48 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.79805853 |
| 49 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.78732776 |
| 50 | FUS_26573619_Chip-Seq_HEK293_Human | 1.75545014 |
| 51 | P300_19829295_ChIP-Seq_ESCs_Human | 1.75294501 |
| 52 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.74928138 |
| 53 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.74891565 |
| 54 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.69134313 |
| 55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.68469241 |
| 56 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.67494485 |
| 57 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.67146042 |
| 58 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.66838919 |
| 59 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.66691684 |
| 60 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.61067118 |
| 61 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.59051781 |
| 62 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.55831136 |
| 63 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.53837108 |
| 64 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53754854 |
| 65 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.50743358 |
| 66 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.50412086 |
| 67 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.49292260 |
| 68 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.49246782 |
| 69 | VDR_22108803_ChIP-Seq_LS180_Human | 1.45893463 |
| 70 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.45023797 |
| 71 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.43828291 |
| 72 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43642324 |
| 73 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.42228088 |
| 74 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.42228088 |
| 75 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.41344912 |
| 76 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.40583872 |
| 77 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.40294754 |
| 78 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.36399239 |
| 79 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.36389634 |
| 80 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.35973774 |
| 81 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33532336 |
| 82 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.33345287 |
| 83 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.32941101 |
| 84 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.32603431 |
| 85 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.30784254 |
| 86 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29704426 |
| 87 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.28331919 |
| 88 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.28103517 |
| 89 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.27981186 |
| 90 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.25897922 |
| 91 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.25830605 |
| 92 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.24269540 |
| 93 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.23949285 |
| 94 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.23543375 |
| 95 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.21411433 |
| 96 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.20855530 |
| 97 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.19742033 |
| 98 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.19311166 |
| 99 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19129460 |
| 100 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.14859332 |
| 101 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.14801354 |
| 102 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.14538826 |
| 103 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.14431547 |
| 104 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.13980680 |
| 105 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.13943788 |
| 106 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13943788 |
| 107 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.13343438 |
| 108 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.13067176 |
| 109 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.13067176 |
| 110 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.12114578 |
| 111 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.11571865 |
| 112 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.11068735 |
| 113 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.10702865 |
| 114 | EWS_26573619_Chip-Seq_HEK293_Human | 1.10325056 |
| 115 | TCF4_23295773_ChIP-Seq_U87_Human | 1.09880448 |
| 116 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09440138 |
| 117 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09379897 |
| 118 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.08896114 |
| 119 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.08485475 |
| 120 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07667094 |
| 121 | JUN_21703547_ChIP-Seq_K562_Human | 1.07477917 |
| 122 | TP53_16413492_ChIP-PET_HCT116_Human | 1.06938252 |
| 123 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.06773982 |
| 124 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.06170737 |
| 125 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.06051548 |
| 126 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.05808949 |
| 127 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.05194740 |
| 128 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04716010 |
| 129 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.04228436 |
| 130 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03331906 |
| 131 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03161537 |
| 132 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.02838148 |
| 133 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.02651851 |
| 134 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02605764 |
| 135 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.02456823 |
| 136 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.01782206 |
| 137 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.99688713 |
| 138 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99411224 |
| 139 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.98730718 |
| 140 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.97946437 |
| 141 | KDM2B_26808549_Chip-Seq_REH_Human | 0.97517127 |
| 142 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97415750 |
| 143 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.97162769 |
| 144 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.97159032 |
| 145 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.96740744 |
| 146 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.96459054 |
| 147 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96297632 |
| 148 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.95316180 |
| 149 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.95301898 |
| 150 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.95279532 |
| 151 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.95205567 |
| 152 | SPI1_23127762_ChIP-Seq_K562_Human | 0.94980497 |
| 153 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94911796 |
| 154 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94802299 |
| 155 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.94739986 |
| 156 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.94521175 |
| 157 | AR_25329375_ChIP-Seq_VCAP_Human | 0.94255200 |
| 158 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.93890500 |
| 159 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.93426905 |
| 160 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91581386 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 4.37622384 |
| 2 | MP0000920_abnormal_myelination | 3.99786208 |
| 3 | MP0006054_spinal_hemorrhage | 3.82028937 |
| 4 | MP0003303_peritoneal_inflammation | 3.13788481 |
| 5 | MP0002877_abnormal_melanocyte_morpholog | 3.12102990 |
| 6 | MP0003724_increased_susceptibility_to | 3.11423392 |
| 7 | MP0003880_abnormal_central_pattern | 3.07394685 |
| 8 | MP0004270_analgesia | 2.90863013 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.89272391 |
| 10 | MP0001348_abnormal_lacrimal_gland | 2.84168054 |
| 11 | MP0005275_abnormal_skin_tensile | 2.71920339 |
| 12 | MP0005171_absent_coat_pigmentation | 2.63601807 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.60739367 |
| 14 | MP0006082_CNS_inflammation | 2.57426486 |
| 15 | MP0000778_abnormal_nervous_system | 2.51359143 |
| 16 | MP0001905_abnormal_dopamine_level | 2.48572601 |
| 17 | MP0001346_abnormal_lacrimal_gland | 2.48087727 |
| 18 | MP0001958_emphysema | 2.44748211 |
| 19 | MP0004859_abnormal_synaptic_plasticity | 2.39017795 |
| 20 | MP0003279_aneurysm | 2.34884674 |
| 21 | MP0005058_abnormal_lysosome_morphology | 2.33876124 |
| 22 | MP0005409_darkened_coat_color | 2.32973884 |
| 23 | MP0003690_abnormal_glial_cell | 2.22186649 |
| 24 | MP0004742_abnormal_vestibular_system | 2.19515245 |
| 25 | MP0002734_abnormal_mechanical_nocicepti | 2.18108989 |
| 26 | MP0002272_abnormal_nervous_system | 2.12637938 |
| 27 | MP0005257_abnormal_intraocular_pressure | 2.09016267 |
| 28 | MP0001529_abnormal_vocalization | 2.01625667 |
| 29 | MP0010352_gastrointestinal_tract_polyps | 1.95076742 |
| 30 | MP0001835_abnormal_antigen_presentation | 1.90219276 |
| 31 | MP0003828_pulmonary_edema | 1.89649571 |
| 32 | MP0001968_abnormal_touch/_nociception | 1.88417733 |
| 33 | MP0001486_abnormal_startle_reflex | 1.84916333 |
| 34 | MP0002064_seizures | 1.84912535 |
| 35 | MP0009046_muscle_twitch | 1.84664336 |
| 36 | MP0008438_abnormal_cutaneous_collagen | 1.83706324 |
| 37 | MP0003448_altered_tumor_morphology | 1.82657437 |
| 38 | MP0000343_altered_response_to | 1.82437616 |
| 39 | MP0004134_abnormal_chest_morphology | 1.82010550 |
| 40 | MP0003136_yellow_coat_color | 1.81867502 |
| 41 | MP0009745_abnormal_behavioral_response | 1.79395817 |
| 42 | MP0002735_abnormal_chemical_nociception | 1.77318851 |
| 43 | MP0005423_abnormal_somatic_nervous | 1.75944466 |
| 44 | MP0003635_abnormal_synaptic_transmissio | 1.75404710 |
| 45 | MP0002419_abnormal_innate_immunity | 1.73580716 |
| 46 | MP0001299_abnormal_eye_distance/ | 1.73537787 |
| 47 | MP0003191_abnormal_cellular_cholesterol | 1.72743967 |
| 48 | MP0003950_abnormal_plasma_membrane | 1.72408303 |
| 49 | MP0003634_abnormal_glial_cell | 1.70912991 |
| 50 | MP0003566_abnormal_cell_adhesion | 1.70508159 |
| 51 | MP0009764_decreased_sensitivity_to | 1.67092351 |
| 52 | MP0005248_abnormal_Harderian_gland | 1.66036581 |
| 53 | MP0002009_preneoplasia | 1.64816811 |
| 54 | MP0002148_abnormal_hypersensitivity_rea | 1.63550331 |
| 55 | MP0002163_abnormal_gland_morphology | 1.61730857 |
| 56 | MP0002736_abnormal_nociception_after | 1.56347390 |
| 57 | MP0001485_abnormal_pinna_reflex | 1.53829086 |
| 58 | MP0002733_abnormal_thermal_nociception | 1.52342611 |
| 59 | MP0004272_abnormal_basement_membrane | 1.51980141 |
| 60 | MP0005503_abnormal_tendon_morphology | 1.49016218 |
| 61 | MP0005174_abnormal_tail_pigmentation | 1.48194754 |
| 62 | MP0000767_abnormal_smooth_muscle | 1.45497584 |
| 63 | MP0004883_abnormal_blood_vessel | 1.44815276 |
| 64 | MP0004147_increased_porphyrin_level | 1.42938875 |
| 65 | MP0004142_abnormal_muscle_tone | 1.42366150 |
| 66 | MP0005623_abnormal_meninges_morphology | 1.40504412 |
| 67 | MP0001542_abnormal_bone_strength | 1.39231558 |
| 68 | MP0001970_abnormal_pain_threshold | 1.38464657 |
| 69 | MP0002102_abnormal_ear_morphology | 1.37924651 |
| 70 | MP0001440_abnormal_grooming_behavior | 1.35763649 |
| 71 | MP0003632_abnormal_nervous_system | 1.35056818 |
| 72 | MP0000015_abnormal_ear_pigmentation | 1.35023841 |
| 73 | MP0000955_abnormal_spinal_cord | 1.34077247 |
| 74 | MP0005164_abnormal_response_to | 1.32948949 |
| 75 | MP0000372_irregular_coat_pigmentation | 1.31923865 |
| 76 | MP0009250_abnormal_appendicular_skeleto | 1.30919502 |
| 77 | MP0002063_abnormal_learning/memory/cond | 1.30690164 |
| 78 | MP0003172_abnormal_lysosome_physiology | 1.30558503 |
| 79 | MP0001853_heart_inflammation | 1.29918085 |
| 80 | MP0000462_abnormal_digestive_system | 1.28825978 |
| 81 | MP0004885_abnormal_endolymph | 1.28738359 |
| 82 | MP0002882_abnormal_neuron_morphology | 1.26570833 |
| 83 | MP0002067_abnormal_sensory_capabilities | 1.25021407 |
| 84 | MP0004510_myositis | 1.24870749 |
| 85 | MP0002896_abnormal_bone_mineralization | 1.23716006 |
| 86 | MP0003937_abnormal_limbs/digits/tail_de | 1.23703984 |
| 87 | MP0005645_abnormal_hypothalamus_physiol | 1.23500420 |
| 88 | MP0003329_amyloid_beta_deposits | 1.23187059 |
| 89 | MP0008004_abnormal_stomach_pH | 1.22890883 |
| 90 | MP0002572_abnormal_emotion/affect_behav | 1.22759257 |
| 91 | MP0005310_abnormal_salivary_gland | 1.22136989 |
| 92 | MP0002295_abnormal_pulmonary_circulatio | 1.22063428 |
| 93 | MP0004924_abnormal_behavior | 1.21013073 |
| 94 | MP0005386_behavior/neurological_phenoty | 1.21013073 |
| 95 | MP0003221_abnormal_cardiomyocyte_apopto | 1.20843329 |
| 96 | MP0001533_abnormal_skeleton_physiology | 1.19282678 |
| 97 | MP0010307_abnormal_tumor_latency | 1.18557135 |
| 98 | MP0000371_diluted_coat_color | 1.16370892 |
| 99 | MP0002998_abnormal_bone_remodeling | 1.16356694 |
| 100 | MP0005595_abnormal_vascular_smooth | 1.16152228 |
| 101 | MP0002332_abnormal_exercise_endurance | 1.16134798 |
| 102 | MP0001243_abnormal_dermal_layer | 1.12574370 |
| 103 | MP0002184_abnormal_innervation | 1.11284620 |
| 104 | MP0003075_altered_response_to | 1.10889726 |
| 105 | MP0006276_abnormal_autonomic_nervous | 1.10810066 |
| 106 | MP0009785_altered_susceptibility_to | 1.09826013 |
| 107 | MP0005167_abnormal_blood-brain_barrier | 1.08620369 |
| 108 | MP0009384_cardiac_valve_regurgitation | 1.08036801 |
| 109 | MP0002066_abnormal_motor_capabilities/c | 1.06790509 |
| 110 | MP0003183_abnormal_peptide_metabolism | 1.06044491 |
| 111 | MP0002229_neurodegeneration | 1.05859317 |
| 112 | MP0002452_abnormal_antigen_presenting | 1.05389400 |
| 113 | MP0000465_gastrointestinal_hemorrhage | 1.04335475 |
| 114 | MP0003436_decreased_susceptibility_to | 1.03559670 |
| 115 | MP0002090_abnormal_vision | 1.03217770 |
| 116 | MP0002060_abnormal_skin_morphology | 1.02315529 |
| 117 | MP0002254_reproductive_system_inflammat | 1.01816693 |
| 118 | MP0005379_endocrine/exocrine_gland_phen | 1.01710366 |
| 119 | MP0000383_abnormal_hair_follicle | 1.01463054 |
| 120 | MP0004808_abnormal_hematopoietic_stem | 1.01014445 |
| 121 | MP0003385_abnormal_body_wall | 1.00245672 |
| 122 | MP0002752_abnormal_somatic_nervous | 0.99940390 |
| 123 | MP0008057_abnormal_DNA_replication | 0.99296070 |
| 124 | MP0002938_white_spotting | 0.99236576 |
| 125 | MP0010678_abnormal_skin_adnexa | 0.98809495 |
| 126 | MP0001188_hyperpigmentation | 0.96812555 |
| 127 | MP0008569_lethality_at_weaning | 0.96306762 |
| 128 | MP0002095_abnormal_skin_pigmentation | 0.94494285 |
| 129 | MP0001963_abnormal_hearing_physiology | 0.92621045 |
| 130 | MP0001915_intracranial_hemorrhage | 0.92102246 |
| 131 | MP0000427_abnormal_hair_cycle | 0.91767926 |
| 132 | MP0001986_abnormal_taste_sensitivity | 0.91008888 |
| 133 | MP0001545_abnormal_hematopoietic_system | 0.90704676 |
| 134 | MP0005397_hematopoietic_system_phenotyp | 0.90704676 |
| 135 | MP0003938_abnormal_ear_development | 0.90349527 |
| 136 | MP0003453_abnormal_keratinocyte_physiol | 0.89266339 |
| 137 | MP0005197_abnormal_uvea_morphology | 0.88570672 |
| 138 | MP0000647_abnormal_sebaceous_gland | 0.88562631 |
| 139 | MP0003091_abnormal_cell_migration | 0.88374409 |
| 140 | MP0009379_abnormal_foot_pigmentation | 0.87546777 |
| 141 | MP0010368_abnormal_lymphatic_system | 0.87212242 |
| 142 | MP0005000_abnormal_immune_tolerance | 0.86874732 |
| 143 | MP0002751_abnormal_autonomic_nervous | 0.86154622 |
| 144 | MP0005025_abnormal_response_to | 0.86052213 |
| 145 | MP0000428_abnormal_craniofacial_morphol | 0.83458540 |
| 146 | MP0005508_abnormal_skeleton_morphology | 0.83411044 |
| 147 | MP0005390_skeleton_phenotype | 0.82837188 |
| 148 | MP0002108_abnormal_muscle_morphology | 0.82430668 |
| 149 | MP0003631_nervous_system_phenotype | 0.81896985 |
| 150 | MP0001177_atelectasis | 0.81227712 |
| 151 | MP0002152_abnormal_brain_morphology | 0.81005646 |
| 152 | MP0000858_altered_metastatic_potential | 0.80163101 |
| 153 | MP0001879_abnormal_lymphatic_vessel | 0.80141381 |
| 154 | MP0000631_abnormal_neuroendocrine_gland | 0.79022094 |
| 155 | MP0002723_abnormal_immune_serum | 0.77869743 |
| 156 | MP0001790_abnormal_immune_system | 0.76367440 |
| 157 | MP0005387_immune_system_phenotype | 0.76367440 |
| 158 | MP0000026_abnormal_inner_ear | 0.75309812 |
| 159 | MP0010234_abnormal_vibrissa_follicle | 0.75280720 |
| 160 | MP0001661_extended_life_span | 0.75119797 |
| 161 | MP0004811_abnormal_neuron_physiology | 0.74995282 |
| 162 | MP0009278_abnormal_bone_marrow | 0.74954944 |
| 163 | MP0002177_abnormal_outer_ear | 0.74562938 |
| 164 | MP0005165_increased_susceptibility_to | 0.74514779 |
| 165 | MP0003795_abnormal_bone_structure | 0.73798772 |
| 166 | MP0008260_abnormal_autophagy | 0.72354264 |
| 167 | MP0008775_abnormal_heart_ventricle | 0.72302688 |
| 168 | MP0002933_joint_inflammation | 0.71733101 |
| 169 | MP0003122_maternal_imprinting | 0.71618701 |
| 170 | MP0005023_abnormal_wound_healing | 0.71500320 |
| 171 | MP0004947_skin_inflammation | 0.70439963 |
| 172 | MP0002133_abnormal_respiratory_system | 0.70222040 |
| 173 | MP0005388_respiratory_system_phenotype | 0.70222040 |
| 174 | MP0002115_abnormal_skeleton_extremities | 0.69328167 |
| 175 | MP0001851_eye_inflammation | 0.63900658 |
| 176 | MP0000604_amyloidosis | 0.63854515 |
| 177 | MP0002557_abnormal_social/conspecific_i | 0.63743549 |
| 178 | MP0005646_abnormal_pituitary_gland | 0.61856476 |
| 179 | MP0001501_abnormal_sleep_pattern | 0.61400339 |
| 180 | MP0003755_abnormal_palate_morphology | 0.60325869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 5.87192952 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.87192952 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.87192952 |
| 4 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.77668632 |
| 5 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.77668632 |
| 6 | Sensory axonal neuropathy (HP:0003390) | 5.24474550 |
| 7 | Abnormality of the corticospinal tract (HP:0002492) | 4.69870404 |
| 8 | Neurofibrillary tangles (HP:0002185) | 4.16041553 |
| 9 | Parakeratosis (HP:0001036) | 4.02600342 |
| 10 | Premature rupture of membranes (HP:0001788) | 4.01181452 |
| 11 | Small epiphyses (HP:0010585) | 3.60237927 |
| 12 | Epiphyseal dysplasia (HP:0002656) | 3.53768798 |
| 13 | Akinesia (HP:0002304) | 3.51679338 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 3.47723092 |
| 15 | Termporal pattern (HP:0011008) | 3.30571801 |
| 16 | Insidious onset (HP:0003587) | 3.30571801 |
| 17 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.29442078 |
| 18 | Myocardial infarction (HP:0001658) | 3.12637580 |
| 19 | Disinhibition (HP:0000734) | 3.10503495 |
| 20 | Increased cerebral lipofuscin (HP:0011813) | 3.00491832 |
| 21 | Alacrima (HP:0000522) | 2.99506101 |
| 22 | Recurrent bacterial skin infections (HP:0005406) | 2.99404362 |
| 23 | Peritonitis (HP:0002586) | 2.99037020 |
| 24 | Spastic gait (HP:0002064) | 2.98140061 |
| 25 | Peripheral hypomyelination (HP:0007182) | 2.96613557 |
| 26 | Cortical dysplasia (HP:0002539) | 2.95279664 |
| 27 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.90963660 |
| 28 | Hematochezia (HP:0002573) | 2.88079492 |
| 29 | Metaphyseal dysplasia (HP:0100255) | 2.87160521 |
| 30 | Supranuclear gaze palsy (HP:0000605) | 2.80265037 |
| 31 | Atonic seizures (HP:0010819) | 2.79889208 |
| 32 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.79653663 |
| 33 | Absent frontal sinuses (HP:0002688) | 2.79375394 |
| 34 | Irregular epiphyses (HP:0010582) | 2.77827993 |
| 35 | Aortic dissection (HP:0002647) | 2.74515139 |
| 36 | Recurrent abscess formation (HP:0002722) | 2.72974405 |
| 37 | Cerebral inclusion bodies (HP:0100314) | 2.72596893 |
| 38 | Cerebral hemorrhage (HP:0001342) | 2.68266165 |
| 39 | Hypoplastic pelvis (HP:0008839) | 2.66032797 |
| 40 | Retinal dysplasia (HP:0007973) | 2.62444531 |
| 41 | Dysostosis multiplex (HP:0000943) | 2.62346712 |
| 42 | Autoamputation (HP:0001218) | 2.62064004 |
| 43 | Cupped ear (HP:0000378) | 2.60272428 |
| 44 | Spondylolisthesis (HP:0003302) | 2.58159965 |
| 45 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.52782780 |
| 46 | Follicular hyperkeratosis (HP:0007502) | 2.51690567 |
| 47 | Bladder diverticulum (HP:0000015) | 2.50787384 |
| 48 | Cerebral hypomyelination (HP:0006808) | 2.49649138 |
| 49 | Neuroendocrine neoplasm (HP:0100634) | 2.48104234 |
| 50 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.47821785 |
| 51 | Relative macrocephaly (HP:0004482) | 2.47001856 |
| 52 | Adrenal hypoplasia (HP:0000835) | 2.46662901 |
| 53 | Loss of speech (HP:0002371) | 2.46530150 |
| 54 | Fetal akinesia sequence (HP:0001989) | 2.44829732 |
| 55 | Pheochromocytoma (HP:0002666) | 2.44752628 |
| 56 | Absent septum pellucidum (HP:0001331) | 2.42154029 |
| 57 | Syringomyelia (HP:0003396) | 2.39490338 |
| 58 | Spinal cord lesions (HP:0100561) | 2.39490338 |
| 59 | Limb dystonia (HP:0002451) | 2.39269357 |
| 60 | Spontaneous hematomas (HP:0007420) | 2.38812039 |
| 61 | Abnormality of incisor morphology (HP:0011063) | 2.38715714 |
| 62 | Broad ribs (HP:0000885) | 2.37628941 |
| 63 | Thickened helices (HP:0000391) | 2.37401084 |
| 64 | Stomach cancer (HP:0012126) | 2.36957745 |
| 65 | Vascular tortuosity (HP:0004948) | 2.36585790 |
| 66 | Abnormality of macrophages (HP:0004311) | 2.35918648 |
| 67 | Soft skin (HP:0000977) | 2.35867310 |
| 68 | Decreased lacrimation (HP:0000633) | 2.34236128 |
| 69 | Osteolytic defects of the hand bones (HP:0009699) | 2.33847036 |
| 70 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.33847036 |
| 71 | Eczematoid dermatitis (HP:0000976) | 2.33620657 |
| 72 | Myokymia (HP:0002411) | 2.32222338 |
| 73 | Poor head control (HP:0002421) | 2.30609699 |
| 74 | Conjunctival telangiectasia (HP:0000524) | 2.29406859 |
| 75 | Agnosia (HP:0010524) | 2.28783399 |
| 76 | Ankle contracture (HP:0006466) | 2.28486784 |
| 77 | Deep philtrum (HP:0002002) | 2.28353434 |
| 78 | Genu recurvatum (HP:0002816) | 2.25359414 |
| 79 | Thoracolumbar scoliosis (HP:0002944) | 2.24413492 |
| 80 | Intention tremor (HP:0002080) | 2.20710920 |
| 81 | Upper motor neuron abnormality (HP:0002127) | 2.20656484 |
| 82 | Aortic aneurysm (HP:0004942) | 2.19648116 |
| 83 | Optic neuritis (HP:0100653) | 2.17327055 |
| 84 | Retrobulbar optic neuritis (HP:0100654) | 2.17327055 |
| 85 | Hypothermia (HP:0002045) | 2.17162902 |
| 86 | Dilatation of the ascending aorta (HP:0005111) | 2.16523742 |
| 87 | Short middle phalanx of the 5th finger (HP:0004220) | 2.14906891 |
| 88 | Orchitis (HP:0100796) | 2.14830643 |
| 89 | Arterial tortuosity (HP:0005116) | 2.13486325 |
| 90 | Stridor (HP:0010307) | 2.12602824 |
| 91 | Abnormality of the septum pellucidum (HP:0007375) | 2.11963988 |
| 92 | Abnormal auditory evoked potentials (HP:0006958) | 2.11569064 |
| 93 | Increased serum pyruvate (HP:0003542) | 2.11256100 |
| 94 | Abnormality of glycolysis (HP:0004366) | 2.11256100 |
| 95 | Dysmetria (HP:0001310) | 2.10718809 |
| 96 | Type II lissencephaly (HP:0007260) | 2.10543534 |
| 97 | Protrusio acetabuli (HP:0003179) | 2.09536845 |
| 98 | Large earlobe (HP:0009748) | 2.08967212 |
| 99 | Slow saccadic eye movements (HP:0000514) | 2.07740245 |
| 100 | Decreased skull ossification (HP:0004331) | 2.05999559 |
| 101 | Mild short stature (HP:0003502) | 2.05443472 |
| 102 | Partial agenesis of the corpus callosum (HP:0001338) | 2.05313898 |
| 103 | Progressive inability to walk (HP:0002505) | 2.05310765 |
| 104 | Premature skin wrinkling (HP:0100678) | 2.05249550 |
| 105 | White forelock (HP:0002211) | 2.04488032 |
| 106 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.04360556 |
| 107 | Aplasia of the phalanges of the hand (HP:0009802) | 2.04360556 |
| 108 | Aplasia involving bones of the extremities (HP:0009825) | 2.04360556 |
| 109 | Abnormality of skull ossification (HP:0002703) | 2.02595985 |
| 110 | Septo-optic dysplasia (HP:0100842) | 2.02392726 |
| 111 | Delayed epiphyseal ossification (HP:0002663) | 2.01724218 |
| 112 | Inappropriate behavior (HP:0000719) | 2.01343652 |
| 113 | Mediastinal lymphadenopathy (HP:0100721) | 2.01309474 |
| 114 | Epileptic encephalopathy (HP:0200134) | 2.00468923 |
| 115 | Subacute progressive viral hepatitis (HP:0006572) | 1.97956410 |
| 116 | Autoimmune thrombocytopenia (HP:0001973) | 1.97906588 |
| 117 | Lower limb muscle weakness (HP:0007340) | 1.97658405 |
| 118 | Wormian bones (HP:0002645) | 1.97298005 |
| 119 | Patchy hypopigmentation of hair (HP:0011365) | 1.95291024 |
| 120 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.94979361 |
| 121 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.94072441 |
| 122 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.94072441 |
| 123 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.94072441 |
| 124 | Atrophic scars (HP:0001075) | 1.93468404 |
| 125 | Infantile muscular hypotonia (HP:0008947) | 1.93256666 |
| 126 | Chin dimple (HP:0010751) | 1.93091464 |
| 127 | Apathy (HP:0000741) | 1.92444307 |
| 128 | Mucopolysacchariduria (HP:0008155) | 1.92122793 |
| 129 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.92122793 |
| 130 | Mutism (HP:0002300) | 1.91648267 |
| 131 | Leukodystrophy (HP:0002415) | 1.88195079 |
| 132 | Myelomeningocele (HP:0002475) | 1.88140589 |
| 133 | Ankle clonus (HP:0011448) | 1.88050196 |
| 134 | Conical tooth (HP:0000698) | 1.87483687 |
| 135 | Abnormality of the frontal sinuses (HP:0002687) | 1.87224573 |
| 136 | Anteriorly placed anus (HP:0001545) | 1.86764128 |
| 137 | Scanning speech (HP:0002168) | 1.85725252 |
| 138 | Diminished movement (HP:0002374) | 1.85093622 |
| 139 | Pulmonary artery stenosis (HP:0004415) | 1.83463939 |
| 140 | * Onion bulb formation (HP:0003383) | 1.83177138 |
| 141 | Myositis (HP:0100614) | 1.82921819 |
| 142 | Mitral valve prolapse (HP:0001634) | 1.82702629 |
| 143 | Overgrowth (HP:0001548) | 1.82429270 |
| 144 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.82211322 |
| 145 | Diminished motivation (HP:0000745) | 1.80585621 |
| 146 | Cerebral aneurysm (HP:0004944) | 1.80197098 |
| 147 | Hypoplasia of the iris (HP:0007676) | 1.79840052 |
| 148 | Ulnar claw (HP:0001178) | 1.79484240 |
| 149 | Coronal craniosynostosis (HP:0004440) | 1.79404751 |
| 150 | Anomalous pulmonary venous return (HP:0010772) | 1.78053627 |
| 151 | Abnormality of the periventricular white matter (HP:0002518) | 1.76750071 |
| 152 | Mixed hearing impairment (HP:0000410) | 1.76731280 |
| 153 | Bowel diverticulosis (HP:0005222) | 1.76191446 |
| 154 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.76093793 |
| 155 | Humeroradial synostosis (HP:0003041) | 1.75698840 |
| 156 | Synostosis involving the elbow (HP:0003938) | 1.75698840 |
| 157 | Renal Fanconi syndrome (HP:0001994) | 1.74814432 |
| 158 | Widely spaced teeth (HP:0000687) | 1.74709505 |
| 159 | Hypoplastic ischia (HP:0003175) | 1.74684603 |
| 160 | Abnormal hair whorl (HP:0010721) | 1.73348402 |
| 161 | Abnormality of the vitreous humor (HP:0004327) | 1.72379811 |
| 162 | Broad-based gait (HP:0002136) | 1.72350939 |
| 163 | Pulmonic stenosis (HP:0001642) | 1.71918596 |
| 164 | Blue sclerae (HP:0000592) | 1.70497437 |
| 165 | Asymmetry of the thorax (HP:0001555) | 1.70388722 |
| 166 | Abnormality of the parathyroid morphology (HP:0011766) | 1.69262641 |
| 167 | Prostate neoplasm (HP:0100787) | 1.69262529 |
| 168 | Barrel-shaped chest (HP:0001552) | 1.68311647 |
| 169 | Albinism (HP:0001022) | 1.67724488 |
| 170 | Buphthalmos (HP:0000557) | 1.67466226 |
| 171 | Esophageal varix (HP:0002040) | 1.66822004 |
| 172 | Focal seizures (HP:0007359) | 1.66350760 |
| 173 | Heterochromia iridis (HP:0001100) | 1.62570485 |
| 174 | Meningocele (HP:0002435) | 1.62407275 |
| 175 | Abnormality of the pulmonary veins (HP:0011718) | 1.62295840 |
| 176 | Absent hand (HP:0004050) | 1.61284326 |
| 177 | Hypomagnesemia (HP:0002917) | 1.60940123 |
| 178 | Abnormality of the femoral head (HP:0003368) | 1.60175379 |
| 179 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.60045544 |
| 180 | Mitral stenosis (HP:0001718) | 1.59342397 |
| 181 | Clumsiness (HP:0002312) | 1.59138208 |
| 182 | Acute myeloid leukemia (HP:0004808) | 1.59082416 |
| 183 | Hemoptysis (HP:0002105) | 1.58826871 |
| 184 | Flat cornea (HP:0007720) | 1.58683207 |
| 185 | Recurrent skin infections (HP:0001581) | 1.54200595 |
| 186 | Periodontitis (HP:0000704) | 1.53708067 |
| 187 | Global brain atrophy (HP:0002283) | 1.52670917 |
| 188 | Hepatosplenomegaly (HP:0001433) | 1.52086587 |
| 189 | Curly hair (HP:0002212) | 1.51764549 |
| 190 | Mucosal telangiectasiae (HP:0100579) | 1.47302124 |
| 191 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.47177012 |
| 192 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.46716440 |
| 193 | Bladder carcinoma (HP:0002862) | 1.46490119 |
| 194 | Bladder neoplasm (HP:0009725) | 1.46490119 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 5.20033541 |
| 2 | STK39 | 5.06196027 |
| 3 | BCR | 3.44964836 |
| 4 | TGFBR2 | 3.30518945 |
| 5 | OXSR1 | 3.19721132 |
| 6 | EPHB1 | 2.93652771 |
| 7 | NEK9 | 2.92988627 |
| 8 | GRK7 | 2.54941232 |
| 9 | PKN1 | 2.25110982 |
| 10 | BLK | 2.23676752 |
| 11 | CDK6 | 2.15396500 |
| 12 | ERBB3 | 2.09560835 |
| 13 | PDGFRA | 2.09554696 |
| 14 | LIMK1 | 2.04259599 |
| 15 | ACVR1B | 1.99545790 |
| 16 | PBK | 1.96176745 |
| 17 | PAK6 | 1.91244119 |
| 18 | PRPF4B | 1.85075644 |
| 19 | CASK | 1.83632871 |
| 20 | MAP3K13 | 1.79932143 |
| 21 | MARK1 | 1.78543348 |
| 22 | NEK6 | 1.75665792 |
| 23 | MAPK13 | 1.74199276 |
| 24 | CDK19 | 1.73043140 |
| 25 | MAP3K6 | 1.72251733 |
| 26 | CAMKK2 | 1.72050014 |
| 27 | FGFR2 | 1.70659607 |
| 28 | CSNK1G3 | 1.70485645 |
| 29 | BMPR1B | 1.68405409 |
| 30 | JAK3 | 1.67805935 |
| 31 | WNK4 | 1.66350673 |
| 32 | UHMK1 | 1.64722199 |
| 33 | LATS2 | 1.62495297 |
| 34 | TYK2 | 1.60979810 |
| 35 | MAP3K14 | 1.58177292 |
| 36 | NTRK1 | 1.57039268 |
| 37 | CSNK1A1L | 1.55568374 |
| 38 | CCNB1 | 1.50630930 |
| 39 | MAPKAPK5 | 1.46701548 |
| 40 | TGFBR1 | 1.36303702 |
| 41 | CSNK1G2 | 1.34822348 |
| 42 | CSNK1G1 | 1.33857831 |
| 43 | MET | 1.31997789 |
| 44 | RIPK1 | 1.29858870 |
| 45 | JAK1 | 1.27007078 |
| 46 | WNK1 | 1.25448924 |
| 47 | DYRK2 | 1.25319173 |
| 48 | PAK3 | 1.23636801 |
| 49 | IRAK3 | 1.23113777 |
| 50 | ROCK2 | 1.22076276 |
| 51 | FGR | 1.21665364 |
| 52 | FER | 1.20369329 |
| 53 | MATK | 1.19599660 |
| 54 | JAK2 | 1.18010035 |
| 55 | LATS1 | 1.16778054 |
| 56 | PIK3CG | 1.12911005 |
| 57 | TYRO3 | 1.10858360 |
| 58 | RPS6KA4 | 1.08585744 |
| 59 | EPHA3 | 1.03412409 |
| 60 | PDK2 | 1.02126886 |
| 61 | CSK | 1.01918633 |
| 62 | WEE1 | 1.01287490 |
| 63 | PAK2 | 1.00492011 |
| 64 | MAP2K3 | 0.98701834 |
| 65 | MAP3K4 | 0.98493397 |
| 66 | BRSK2 | 0.98374893 |
| 67 | CDK14 | 0.97141313 |
| 68 | MST4 | 0.95258474 |
| 69 | YES1 | 0.94269825 |
| 70 | ERBB4 | 0.93714622 |
| 71 | DYRK3 | 0.91149186 |
| 72 | FLT3 | 0.91125943 |
| 73 | FES | 0.91062690 |
| 74 | ICK | 0.90947306 |
| 75 | STK3 | 0.89559779 |
| 76 | KSR2 | 0.88928317 |
| 77 | CDK5 | 0.86187020 |
| 78 | EPHA4 | 0.85691573 |
| 79 | TIE1 | 0.83348122 |
| 80 | PLK2 | 0.83063264 |
| 81 | PRKCQ | 0.83031861 |
| 82 | PRKCE | 0.82089522 |
| 83 | TTN | 0.81061619 |
| 84 | CLK1 | 0.79916766 |
| 85 | PLK4 | 0.79872034 |
| 86 | CAMK2D | 0.78971167 |
| 87 | ARAF | 0.75631004 |
| 88 | CAMK2B | 0.75613144 |
| 89 | ROCK1 | 0.75305190 |
| 90 | EIF2AK3 | 0.75175028 |
| 91 | GRK5 | 0.74977365 |
| 92 | STK10 | 0.73389562 |
| 93 | EGFR | 0.72980601 |
| 94 | CAMK2A | 0.71445006 |
| 95 | CDK15 | 0.71131454 |
| 96 | BRD4 | 0.70464577 |
| 97 | CDK18 | 0.70308666 |
| 98 | NUAK1 | 0.69706962 |
| 99 | MARK2 | 0.69531808 |
| 100 | MINK1 | 0.68914905 |
| 101 | ABL1 | 0.68809957 |
| 102 | BMPR2 | 0.68786440 |
| 103 | PAK4 | 0.67135362 |
| 104 | TEC | 0.66301134 |
| 105 | HCK | 0.65774061 |
| 106 | CDK11A | 0.64431243 |
| 107 | MUSK | 0.63607368 |
| 108 | DDR2 | 0.63517310 |
| 109 | MKNK2 | 0.63315790 |
| 110 | EIF2AK2 | 0.63209575 |
| 111 | PKN2 | 0.61657306 |
| 112 | MAPK7 | 0.61579053 |
| 113 | FRK | 0.59800593 |
| 114 | MAP2K7 | 0.59574208 |
| 115 | IRAK1 | 0.58941057 |
| 116 | ZAP70 | 0.58649229 |
| 117 | CAMK1D | 0.58010865 |
| 118 | PIK3CA | 0.57066198 |
| 119 | FYN | 0.56737783 |
| 120 | IKBKB | 0.56193979 |
| 121 | PTK2B | 0.54384895 |
| 122 | TRPM7 | 0.52817068 |
| 123 | MAP3K3 | 0.52738403 |
| 124 | RET | 0.50667773 |
| 125 | GSK3A | 0.50179059 |
| 126 | PDGFRB | 0.49818014 |
| 127 | LYN | 0.49694941 |
| 128 | SGK494 | 0.48613428 |
| 129 | SGK223 | 0.48613428 |
| 130 | MOS | 0.47851372 |
| 131 | NLK | 0.47748901 |
| 132 | CAMK2G | 0.47524709 |
| 133 | STK24 | 0.46865202 |
| 134 | MKNK1 | 0.45874392 |
| 135 | MAP3K9 | 0.44663767 |
| 136 | DMPK | 0.44484562 |
| 137 | CAMK1G | 0.44035269 |
| 138 | KSR1 | 0.42176245 |
| 139 | EPHB2 | 0.42156566 |
| 140 | STK38L | 0.41408676 |
| 141 | PHKG1 | 0.41277577 |
| 142 | PHKG2 | 0.41277577 |
| 143 | TAF1 | 0.40911808 |
| 144 | IRAK4 | 0.40807400 |
| 145 | NTRK2 | 0.40576206 |
| 146 | IGF1R | 0.40209879 |
| 147 | PLK3 | 0.39999136 |
| 148 | OBSCN | 0.39129699 |
| 149 | PRKG1 | 0.38168404 |
| 150 | RAF1 | 0.37437472 |
| 151 | MAP3K2 | 0.37221558 |
| 152 | ADRBK2 | 0.36558520 |
| 153 | IRAK2 | 0.36057589 |
| 154 | NTRK3 | 0.35321038 |
| 155 | IKBKE | 0.34494832 |
| 156 | ADRBK1 | 0.32894819 |
| 157 | MELK | 0.31124006 |
| 158 | ABL2 | 0.29781605 |
| 159 | INSR | 0.29350287 |
| 160 | KIT | 0.29185017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.44114596 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.46250723 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.67888335 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 2.33144313 |
| 5 | Axon guidance_Homo sapiens_hsa04360 | 2.25822862 |
| 6 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.25275724 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.11215921 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.03508503 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.01582900 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.01136904 |
| 11 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.91752890 |
| 12 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.83625954 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 1.80816013 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 1.80760185 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.80032945 |
| 16 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.72105263 |
| 17 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.66724238 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.64773496 |
| 19 | * Serotonergic synapse_Homo sapiens_hsa04726 | 1.63715720 |
| 20 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.61213827 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.57813403 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52892973 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.49813048 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.47563299 |
| 25 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.44050793 |
| 26 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.43881949 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.43587990 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.38136904 |
| 29 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 1.35697428 |
| 30 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.33431377 |
| 31 | Parkinsons disease_Homo sapiens_hsa05012 | 1.32699598 |
| 32 | Amoebiasis_Homo sapiens_hsa05146 | 1.32057730 |
| 33 | Hepatitis B_Homo sapiens_hsa05161 | 1.30066520 |
| 34 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.29433704 |
| 35 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.27394053 |
| 36 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.27074027 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.26599774 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.25549798 |
| 39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.23432691 |
| 40 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.20573209 |
| 41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.20428521 |
| 42 | Alzheimers disease_Homo sapiens_hsa05010 | 1.20358983 |
| 43 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.18585913 |
| 44 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.18247998 |
| 45 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.16225239 |
| 46 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.12598211 |
| 47 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.12177928 |
| 48 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.11282860 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.11259481 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.10943859 |
| 51 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.10224409 |
| 52 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.09959291 |
| 53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.09681458 |
| 54 | Measles_Homo sapiens_hsa05162 | 1.07928881 |
| 55 | Malaria_Homo sapiens_hsa05144 | 1.07885766 |
| 56 | * Ras signaling pathway_Homo sapiens_hsa04014 | 1.06616247 |
| 57 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.05870501 |
| 58 | * Morphine addiction_Homo sapiens_hsa05032 | 1.04664669 |
| 59 | * GABAergic synapse_Homo sapiens_hsa04727 | 1.04278757 |
| 60 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.02993773 |
| 61 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.02978427 |
| 62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01865855 |
| 63 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.01818487 |
| 64 | Bladder cancer_Homo sapiens_hsa05219 | 1.01616974 |
| 65 | Protein export_Homo sapiens_hsa03060 | 1.00404699 |
| 66 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.97906595 |
| 67 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.97011549 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.96890120 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.94683911 |
| 70 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.92862556 |
| 71 | Allograft rejection_Homo sapiens_hsa05330 | 0.92468573 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.92423229 |
| 73 | Gap junction_Homo sapiens_hsa04540 | 0.91691040 |
| 74 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90994856 |
| 75 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.90937316 |
| 76 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.90307782 |
| 77 | Nicotine addiction_Homo sapiens_hsa05033 | 0.90265088 |
| 78 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.88495370 |
| 79 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 0.88331840 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.88060536 |
| 81 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.87459838 |
| 82 | Shigellosis_Homo sapiens_hsa05131 | 0.87030632 |
| 83 | * Circadian entrainment_Homo sapiens_hsa04713 | 0.86225393 |
| 84 | Focal adhesion_Homo sapiens_hsa04510 | 0.85196845 |
| 85 | Tight junction_Homo sapiens_hsa04530 | 0.82964954 |
| 86 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.82804223 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.82241655 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.80129222 |
| 89 | Cocaine addiction_Homo sapiens_hsa05030 | 0.80114715 |
| 90 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.80091708 |
| 91 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.80057851 |
| 92 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.80014293 |
| 93 | Phagosome_Homo sapiens_hsa04145 | 0.79884376 |
| 94 | Adherens junction_Homo sapiens_hsa04520 | 0.79734207 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | 0.79043208 |
| 96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78831605 |
| 97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.78678223 |
| 98 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.77566096 |
| 99 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.76370001 |
| 100 | Apoptosis_Homo sapiens_hsa04210 | 0.75932822 |
| 101 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.75742920 |
| 102 | Renin secretion_Homo sapiens_hsa04924 | 0.75355311 |
| 103 | Salivary secretion_Homo sapiens_hsa04970 | 0.75332826 |
| 104 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74980972 |
| 105 | Olfactory transduction_Homo sapiens_hsa04740 | 0.74726161 |
| 106 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.72421348 |
| 107 | Colorectal cancer_Homo sapiens_hsa05210 | 0.72409450 |
| 108 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.72124614 |
| 109 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.71746643 |
| 110 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71559205 |
| 111 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70958826 |
| 112 | Salmonella infection_Homo sapiens_hsa05132 | 0.69738165 |
| 113 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.69459576 |
| 114 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.69043741 |
| 115 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.67924250 |
| 116 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.67817611 |
| 117 | Huntingtons disease_Homo sapiens_hsa05016 | 0.67702957 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67020188 |
| 119 | Taste transduction_Homo sapiens_hsa04742 | 0.65720009 |
| 120 | Platelet activation_Homo sapiens_hsa04611 | 0.65401889 |
| 121 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.64986951 |
| 122 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64338859 |
| 123 | Proteasome_Homo sapiens_hsa03050 | 0.63675496 |
| 124 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63100131 |
| 125 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.63092871 |
| 126 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62804279 |
| 127 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.62459000 |
| 128 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.61999085 |
| 129 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61876046 |
| 130 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.61279162 |
| 131 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.61261725 |
| 132 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60441449 |
| 133 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60182880 |
| 134 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59282626 |
| 135 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.58518010 |
| 136 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.58255570 |
| 137 | Long-term potentiation_Homo sapiens_hsa04720 | 0.57418024 |
| 138 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.56536910 |
| 139 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.55642964 |
| 140 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55327991 |
| 141 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55176815 |
| 142 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.53854532 |
| 143 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.53478979 |
| 144 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53255684 |
| 145 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52760278 |
| 146 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.52673564 |
| 147 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.52313222 |
| 148 | Melanoma_Homo sapiens_hsa05218 | 0.52277142 |
| 149 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51199786 |
| 150 | Prostate cancer_Homo sapiens_hsa05215 | 0.50630864 |
| 151 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.50531306 |
| 152 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.50344380 |
| 153 | Glioma_Homo sapiens_hsa05214 | 0.47746132 |
| 154 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47366890 |
| 155 | Asthma_Homo sapiens_hsa05310 | 0.47099729 |
| 156 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46501838 |
| 157 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.46250847 |
| 158 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45855666 |
| 159 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.45044694 |
| 160 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.44576888 |
| 161 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.42469680 |
| 162 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42187936 |
| 163 | Prion diseases_Homo sapiens_hsa05020 | 0.41973875 |
| 164 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41732784 |

